Login to Your Account



Scandal Hits Bottom Line

GSK’s China Woes Continue; Posts 61% 3Q Sales Plunge

By Shannon Ellis
Staff Writer

Friday, October 25, 2013

SHANGHAI – In the wake of a high-profile corruption scandal, Glaxosmithkline plc’s sales in China plunged in the third quarter.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription